Experimental Drug Is Brought From the U.S. to Lito Sousa Which Will Be a Pioneer in Human Treatment
4 Articles
4 Articles
Understand how Creutzfeldt-Jakob, the influencer's disease Lito Sousa Lito Sousa will begin testing the substance for a test treatment against Creutzfeldt-Jakob. The influencer will be the first person in the world to test the product, which can open doors on the findings for the disease, still unhealed. The substance is the ALN-6457 from the pharmaceutical company Regeneron in the United States. There is not much published about it because it h…
Lito Sousa's wife, Mila Seidl, updated on Monday (14) the health status of the influencer, who received an experimental substance for Creutzfeldt-Jakob's disease. According to her, Lito had no complications caused by the treatment and remains stable in the ICU, where he has been hospitalized since last Tuesday (8) for complications of the disease itself. Read more (09/14/2026
The influencer Lito Sousa will use ALN-6457 to treat Creutzfeldt-Jakob disease
Technology acts on the genetic instructions of cells to try to decrease the rate of brain degradation
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
